Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia
Clinical trial NCT05248685 · WITHDRAWN
Trial details
- NCT number
- NCT05248685
- Sponsor
- Beijing Boren Hospital
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2023-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.